Financials
- Market Capitalization 1.82 B
- Employee 104
- Founded 2005
- CEO N/A
- Website www.anaptysbio.com
- Headquarter Delaware, United States
- FIGI BBG0026ZDHR0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-54.37
売上高対価格比率
6.88
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2046 | BCAX Bicara Therapeutics Inc. - Common Stock | 28.10 USD | -0.18% | -6.05% | +30.58% | +94.60% | 1.85 B USD | ||
| 2055 | PGEN Precigen, Inc. - Common Stock | 5.12 USD | -0.97% | -5.19% | +6.44% | +175.27% | 1.83 B USD | ||
| 2059 | ZBIO Zenas BioPharma, Inc. - Common Stock | 28.78 USD | +3.23% | +5.19% | +53.41% | +8.77% | 1.82 B USD | ||
| 2060 | STOK Stoke Therapeutics, Inc. - Common Stock | 29.13 USD | -1.12% | -11.32% | -3.96% | +146.24% | 1.81 B USD |